Skip to main content

Find Clinical Trials

Home
Conditions
Pathologic Stage IIID Cutaneous Melanoma AJCC v8

Clinical trial condition

Pathologic Stage IIID Cutaneous Melanoma AJCC v8

Explore clinical trials studying Pathologic Stage IIID Cutaneous Melanoma AJCC v8. Study availability and eligibility vary by location and protocol.

13 public trials 3 recruiting studies

Refine in advanced search Browse all conditions

Pathologic Stage IIID Cutaneous Melanoma AJCC v8 trial results

Active, Not Recruiting

Tocilizumab, Ipilimumab, and Nivolumab for the Treatment of Advanced Melanoma, Non-Small Cell Lung Cancer, or Urothelial Carcinoma

NCT04940299

Conditions: Bronchial Neoplasms, Carcinoma, Bronchogenic, Carcinoma, Non-Small-Cell Lung, +72 more
Locations: M D Anderson Cancer Center Houston, Texas, United States

View Trial Details

Active, Not Recruiting

Immune Related Toxicity and Symptom Burden in Chronic Cancer Survivors With Melanoma Receiving Adjuvant Immunotherapy With Immune Checkpoint Inhibitors

NCT04990726

Conditions: Clinical Stage III Cutaneous Melanoma AJCC v8, Melanoma, Melanoma Stage IV, +17 more
Locations: M D Anderson Cancer Center Houston, Texas, United States

View Trial Details

Active, Not Recruiting

Neoadj Admin Autologous Tumor Infiltrating Lymphocytes & Pembrolizumab for Treatment of Adv Melanoma Patients

NCT05176470

Conditions: Locally Advanced Melanoma, Melanoma, Neoplasms, +14 more
Locations: Ohio State University Comprehensive Cancer Center Columbus, Ohio, United States

View Trial Details